Found 14 matching trials
Tumor Microenvironment in Gastric Cancer Patients Treated With Combined Immunotherapy and Chemotherapy N/A The goal of this study is to analyze the tumor microenvironment (TME) in ga...
Show More Location
Chinese PLA General Hospital
Learn More & Join Trial
An Investigational Study of Immunotherapy Combinations With Chemotherapy in Patients With Gastric or Gastroesophageal Junction (GEJ) Cancers PHASE2 The purpose of this study is to determine the efficacy and safety of invest...
Show More Location
Local Institution - 0049
Learn More & Join Trial
ONO-4538 Phase II Rollover Study (ONO-4538-98) PHASE2 This study is intended to confirm the long-term safety of ONO-4538 in pan-t...
Show More Location
Chiba Clinical Site1
Learn More & Join Trial
A Study Evaluating Bemarituzumab in Combination With Other Anti-cancer Therapies in Subjects With Previously Untreated Advanced Gastric or Gastroesophageal Junction Cancer. PHASE1 The main objectives of this study are to evaluate the safety and tolerabili...
Show More Location
Northport Veterans Affairs Medical Center
Learn More & Join Trial
QL1706-SOX vs SOX Alone as Neoadjuvant Therapy for Resectable Diffuse-Type Gastric Cancer PHASE2 The goal of this randomized, open-label, phase II clinical trial is to dete...
Show More Location
First Affiliated Hospital with Nanjing Medical University
Learn More & Join Trial
A Study of PD-1 Inhibitors Combined With Fruquintinib and Chemotherapy in First-line Treatment of HER2-negative Advanced G/GEJ Cancer NA This is an open-label, single-arm, single-center clinical study to investig...
Show More Location
Fudan University ShangHai Cancer Center
Learn More & Join Trial
Study of Adjuvant Chemotherapy With or Without PD-1 Inhibitors and Chemoradiotherapy in Resected pN3 Gastric (G) or GEJ Adenocarcinoma PHASE3 The purpose of the study is to evaluate the efficacy and safety of postoper...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
Nivolumab, S-1 Combined With Oxaliplatin Versus Nivolumab as Neoadjuvant Therapy in Advanced Gastric Cancer PHASE2 The trial is a prospective, randomized, controlled phase Ⅱ study which will...
Show More Location
Multiple Locations
Learn More & Join Trial
Timing of Minimally Invasive Local Treatment After First-Line Systemic Therapy in Oligometastatic Esophageal or Gastric Adenocarcinoma PHASE2 Purpose of the Study:
This clinical study investigates whether a shorter o...
Show More Location
Amsterdam University Medical Center
Learn More & Join Trial
Nivolumab Combined With SOX Used in the Perioperative Treatment PHASE2 To evaluate the pathological complete response rate (pCR) of nivolumab comb...
Show More Location
Zhejiang Cancer Hospital
Learn More & Join Trial